ORKA (Oruka Therapeutics) Inventories, Other: $0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ORKA Oruka Therapeutics Inc ORKA
12 GF Score
Price $107.96
! 2 Warning Signs
View Full Analysis

What is Oruka Therapeutics Inventories, Other?

Oruka Therapeutics ORKA +2.96% 12 Inventories, Other is $0.00 Mil as of Jun. 2026. GuruFocus rates ORKA with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Oruka Therapeutics's other inventories for the quarter that ended in Jun. 2026 was $0.00 Mil.

Oruka Therapeutics Inventories, Other Historical Data

* Premium members only.

The historical data trend for Oruka Therapeutics's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oruka Therapeutics Inventories, Other Chart

Oruka Therapeutics Annual Data
Trend Dec24 Dec25
Inventories, Other
0.00 0.00

Oruka Therapeutics Quarterly Data
Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ORKA
12GF Score
Oruka Therapeutics Inc ORKA
Inventories, Other is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oruka Therapeutics Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Frequently Asked Questions Learn more about Inventories, Other →
What does a Inventories, Other of $0.00 Mil mean?
Oruka Therapeutics (ORKA) has a Inventories, Other of $0.00 Mil as of Jun. 2026. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Oruka Therapeutics and its competitors.
Is Oruka Therapeutics' Inventories, Other too high?
Oruka Therapeutics' current Inventories, Other is $0.00 Mil. Overall, Oruka Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Oruka Therapeutics' Inventories, Other compare to DNTH and SRRK?
Oruka Therapeutics' Inventories, Other of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Other for a Biotechnology company?
A good Inventories, Other depends on the Biotechnology industry context. However, Inventories, Other should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Other mean?
A high Inventories, Other can signal that a stock is expensive relative to its fundamentals. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Oruka Therapeutics and its competitors. Oruka Therapeutics's current Inventories, Other is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oruka Therapeutics stock overvalued right now?
Oruka Therapeutics (ORKA) has a current Inventories, Other of $0.00 Mil. The current Inventories, Other is $0.00 Mil. Oruka Therapeutics' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Other calculated?
Inventories, Other is calculated from a company's financial statements. For Oruka Therapeutics (ORKA), the current Inventories, Other is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oruka Therapeutics Business Description

Other Exchanges HQ1:Germany
Address 855 Oak Grove Avenue, Suite 100, Menlo Park, CA, USA, 94025
Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.
12GF Score

Get the complete analysis for ORKA

Inventories, Other is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$107.96
Price